Article Text
Review
Swedish registers to examine drug safety and clinical issues in RA
Abstract
Data from several different monitoring systems are examined. The potential for registers based on data obtained from clinical practice, and linkage of such data to national health and population registers, is discussed. The approach described is a possible prototype for long term surveillance systems needed for the safe introduction of new treatments.
- ACR, American College of Rheumatology
- ARTIS, Anti-rheumatic therapies in Sweden
- CI, confidence interval
- DAS28, 28 joint count Disease Activity Score
- DMARDs, disease modifying antirheumatic drugs
- HAQ, Health Assessment Questionnaire
- MPA, Medical Products Agency
- RA, rheumatoid arthritis
- RR, relative risk
- SSATG, South Swedish Anti-TNF Group Register
- STURE, Stockholm Tumor Necrosis Factor-α Follow-up Registry
- TNF, tumour necrosis factor
- VAS, visual analogue scale
- Sweden
- tumour necrosis factor
- RA
- register
- epidemiology
Statistics from Altmetric.com
- ACR, American College of Rheumatology
- ARTIS, Anti-rheumatic therapies in Sweden
- CI, confidence interval
- DAS28, 28 joint count Disease Activity Score
- DMARDs, disease modifying antirheumatic drugs
- HAQ, Health Assessment Questionnaire
- MPA, Medical Products Agency
- RA, rheumatoid arthritis
- RR, relative risk
- SSATG, South Swedish Anti-TNF Group Register
- STURE, Stockholm Tumor Necrosis Factor-α Follow-up Registry
- TNF, tumour necrosis factor
- VAS, visual analogue scale